Results 261 to 270 of about 20,213 (273)
Some of the next articles are maybe not open access.
The Challenges and Promise of Complement Therapeutics for Ocular Diseases
Frontiers in Immunology, 2019Dong Ho Park+2 more
exaly
Advanced drug delivery and targeting technologies for the ocular diseases
BioImpacts, 2016Yadollah Omidi+2 more
exaly
Fundamentals, challenges, and nanomedicine‐based solutions for ocular diseases
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 2019Dadi A Srinivasarao, Dhirendra S Katti
exaly
Understanding, recognizing, and managing toxicities of targeted anticancer therapies
Ca-A Cancer Journal for Clinicians, 2013exaly
Ocular blood flow in glaucoma – the Leuven Eye Study
Acta Ophthalmologica, 2016Abraham Shibesh+2 more
exaly
Cancer Excision from Eyelids and Ocular Adnexa: The Mohs Fresh Tissue Technique and Reconstruction
Ca-A Cancer Journal for Clinicians, 1982exaly
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Nature Reviews Drug Discovery, 2006exaly
Brush up on Your Pathology: Intra Ocular Pressure and Tonometry
Clinical and Experimental Optometry, 1970openaire +2 more sources